AAAmneh Alrabie

Amneh Alrabie

*This is an algorithmically generated author record based on publicly available information.

Amneh Alrabie has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Morphological, histopathological, and immunohistochemical changes in tissues of adult male Sprague-Dawley rats orally treated with isotretinoin

    by Ahmad Khalil, Amneh Alrabie, Tareq Al-Omari, Hasan Abo Siam, Doaa Ghorab

    Isotretinoin (ISO) is the most effective drug prescribed by dermatologists for the treatment of acne vulgaris and other clinical skin cases. A significant obstacle to using ISO is concerns regarding its adverse effect profile. Despite the well-established reproductive toxicity in females, information on the effects on human male fertility is scarce, contradictory, and inconclusive. This study aimed to investigate the potential histological and histochemical effects of ISO. Isotretinoin was administered orally for seven successive days to Sprague Dawley male rats in a 5-20 mg/kg/day dose range. Standard histological and immunohistochemical techniques were used to evaluate ISO side effects. High doses of ISO led to infiltration of inflammatory cells in hepatic tissues, atrophy of the kidney glomeruli, and collapse of testicular compartments. Decreased E2F4 production was positively correlated to a reduced rate of spermatogenesis. The findings provide further evidence for ISO's cytotoxic and reprotoxic potencies. These effects are probably partly due to slowing down the expression of an E2F4 transcription factor. The dysregulated gene may play an essential role in spermatogenesis. The diagnostic value of the E2F4 gene needs to be further validated by different proteomics approaches, and its precise role in spermatogenesis needs to be investigated.

  • Assessment of the In Vivo Reprotoxicity of Isotretinoin in Sprague-Dawley Male Rat

    by Ahmad Khalil, Mai Daradkeh, Amneh Alrabie, Hasan Abo Siam

    Background: Isotretinoin (ISO) belongs to a family of drugs called retinoids. It is the most effective drug prescribed by dermatologists for the treatment of the inflammatory disease, acne vulgaris. A significant barrier to the use of ISO has worries regarding its adverse effect profile. Despite the well-recognized reproductive toxicity and teratogenicity in females, there is no warning related to the use by male patients in the medication prospectus. Current data on the effects on human male fertility is contradictory and inconclusive. Objectives: This study was undertaken to investigate the potential effects of ISO oral doses in the Sprague–Dawley male rat germ cells using the sperm morphology assay. Also, the serum levels of the follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone were measured. Methods: The rat groups were given varying ISO doses via gastric gavage for seven consecutive days. The epididymis sperm specimens were microscopically examined for the following reproductive toxicity parameters: sperm concentration, examined viability, motility, and morphology. The serum FSH, LH, and testosterone levels were measured by using the corresponding enzyme-linked immunosorbent assay (ELISA) kit. The data were analyzed statistically by one-way analysis of variance (ANOVA) followed by the Tukey test at P ≤ 0.05 significance level. Results: The results indicated that the drug did not significantly increase the sex hormone levels but notably affected both the sperm quantity and quality. Conclusion: These observations suggest that ISO was reprotoxic, and future therapies should be further reassessed.